What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Raj K. Puri mainly focuses on Molecular biology, Receptor, Interleukin 13, Immunology and Interleukin 4.
His Molecular biology research incorporates elements of Tyrosine kinase, Embryoid body and Stem cell, Cell biology.
In his work, Differentially expressed genes is strongly intertwined with Gene expression profiling, which is a subfield of Stem cell.
Raj K. Puri has researched Receptor in several fields, including Cell culture, Pseudomonas exotoxin, Protein subunit and Fusion protein.
His studies deal with areas such as Exotoxin, Cytotoxic T cell, Cancer cell and Glioma as well as Pseudomonas exotoxin.
His work carried out in the field of Immunology brings together such families of science as Fibrosis, Pulmonary fibrosis and Lung.
His most cited work include:
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements (1880 citations)
- IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. (681 citations)
- The Microarray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models (648 citations)
What are the main themes of his work throughout his whole career to date?
Raj K. Puri mainly investigates Cancer research, Receptor, Molecular biology, Immunology and Pseudomonas exotoxin.
In his study, which falls under the umbrella issue of Cancer research, Cancer and Toxicity is strongly linked to Pathology.
His studies in Receptor integrate themes in fields like Cell culture and Interleukin 13, Interleukin 4.
His Molecular biology research includes themes of Endocrinology, DNA microarray, Gene expression, Transfection and Cell biology.
The Immunology study combines topics in areas such as Pulmonary fibrosis and Combination therapy.
His Pseudomonas exotoxin study combines topics in areas such as Exotoxin, Virology, Immunotoxin, Fusion protein and Cytotoxic T cell.
He most often published in these fields:
- Cancer research (31.65%)
- Receptor (26.98%)
- Molecular biology (25.90%)
What were the highlights of his more recent work (between 2012-2021)?
- Cancer research (31.65%)
- Cancer (13.67%)
- Immunology (23.38%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Cancer, Immunology, Internal medicine and Interleukin-13 receptor.
His Cancer research research is multidisciplinary, incorporating elements of Cell culture, Head and neck squamous-cell carcinoma, Receptor, Immunotoxin and Pseudomonas exotoxin.
His Pseudomonas exotoxin study incorporates themes from Cytotoxic T cell, Clonogenic assay, Glioma and Pathology.
His Immune system study combines topics from a wide range of disciplines, such as Cellular differentiation and Gene expression profiling.
In his research, CD3 is intimately related to Molecular biology, which falls under the overarching field of Gene expression profiling.
His Proinflammatory cytokine research incorporates themes from Fibrosis and Interleukin 13.
Between 2012 and 2021, his most popular works were:
- MSC-based product characterization for clinical trials: an FDA perspective (272 citations)
- Targeting of IL-4 and IL-13 receptors for cancer therapy. (92 citations)
- Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma (56 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Raj K. Puri focuses on Cancer, Immunology, Clinical trial, Cell and Internal medicine.
His Cancer study integrates concerns from other disciplines, such as Immunohistochemistry, Immunostaining and Intensive care medicine.
The Immunology study combines topics in areas such as A549 cell and Silicosis.
His research in Cell intersects with topics in Mesenchymal stem cell, Stem cell and Cell biology.
His work in CD24 tackles topics such as Cancer research which are related to areas like Common gamma chain.
His study in Cancer stem cell is interdisciplinary in nature, drawing from both Receptor, Immune receptor, Janus kinase 1 and Signal transduction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
